Found: 7
Select item for more details and to access through your institution.
MFAP5 facilitates the aggressiveness of intrahepatic Cholangiocarcinoma by activating the Notch1 signaling pathway.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. 1, doi. 10.1186/s13046-019-1477-4
- By:
- Publication type:
- Article
Platelet‐Derived Growth Factor C Facilitates Malignant Behavior of Pancreatic Ductal Adenocarcinoma by Regulating SREBP1 Mediated Lipid Metabolism.
- Published in:
- Advanced Science, 2024, v. 11, n. 40, p. 1, doi. 10.1002/advs.202407069
- By:
- Publication type:
- Article
Targeting Super‐Enhancers via Nanoparticle‐Facilitated BRD4 and CDK7 Inhibitors Synergistically Suppresses Pancreatic Ductal Adenocarcinoma.
- Published in:
- Advanced Science, 2020, v. 7, n. 7, p. 1, doi. 10.1002/advs.201902926
- By:
- Publication type:
- Article
YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 6, p. 1, doi. 10.1002/ctm2.848
- By:
- Publication type:
- Article
ADAR1 promotes cisplatin resistance in intrahepatic cholangiocarcinoma by regulating BRCA2 expression through A‐to‐I editing manner.
- Published in:
- Cell Proliferation, 2024, v. 57, n. 10, p. 1, doi. 10.1111/cpr.13659
- By:
- Publication type:
- Article
Values of a novel pyroptosis-related genetic signature in predicting outcome and immune status of pancreatic ductal adenocarcinoma.
- Published in:
- Gastroenterology Report, 2022, v. 10, p. 1, doi. 10.1093/gastro/goac051
- By:
- Publication type:
- Article
EYA4 inhibits hepatocellular carcinoma by repressing MYCBP by dephosphorylating β‐catenin at Ser552.
- Published in:
- Cancer Science, 2019, v. 110, n. 10, p. 3110, doi. 10.1111/cas.14159
- By:
- Publication type:
- Article